Corrigendum: Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression

Front Immunol. 2020 Oct 28:11:592865. doi: 10.3389/fimmu.2020.592865. eCollection 2020.

¹ Department of Clinical Immunology, Sun Yat-sen University Third Affiliated Hospital, Guangzhou, China.
² INEM UMR 7355 CNRS and University of Orleans, Orléans, France.
³ Immunology and Virology Laboratory, Nanoscience and Nanotechnology Center, Universidad de las Fuerzas Armadas, ESPE, Sangolquí, Ecuador.
⁴ UMR 1282 Infectiologie Animale et Santé Publique, Université de Tours -INRA, Tours, France.
⁵ Department of Internal Medicine, Ohio State College of Medicine, Columbus, OH, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.00702.].

Keywords: IL-22; IL-33/ST2 receptor; Toxoplasma gondii; innate immunity; neutralizing antibody; parasite-induced ileitis.